Actively Recruiting

Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID06754995

Diagnostic Feasibility of 100 Hz Tetanic Stimulation in the Perioperative Setting in Patients With Normal and Abnormal ENG: a Pilot Study

Led by University of Debrecen · Updated on 2025-03-27

40

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the use of 100 Hz tetanic stimulation with an electromyography (EMG) device to study postoperative residual neuromuscular block in anaesthetized patients. The study aims to find out if fatigue develops with this stimulation in patients who have either normal or abnormal baseline electroneurographic (ENG) findings. This research also explores how chronic conditions affecting peripheral nerves, like polyneuropathy, may impact the test's usefulness. During the study, the ulnar nerve at the carpal tunnel is stimulated supramaximally, and the electric response of the abductor digiti minimi muscle is recorded using the Alpine Biomed ENG-EMG device with Keypoint software. Patients are grouped based on their initial ENG results into normal or abnormal ENG groups. Tetanic stimulation at frequencies of 60 and 100 Hz is applied for 5 seconds to assess responses. Participants undergo ENG testing after anesthesia induction, with monitoring lasting up to one hour during anesthesia. No further ENG measurements occur postoperatively. The study evaluates the 100 Hz tetanic fade response and the diagnostic feasibility of EMG in assessing the neuromuscular safety margin. Participants' arms are positioned and prepared for electrode placement following standard procedures.

CONDITIONS

Brief Title

Diagnostic Feasibility of 100 Hz Tetanic Stimulation

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • ASA physical status classification 1 to 3
  • Body mass index between 18.5 and 25 (normal body weight)
  • Patient is lying on their back (supine position) with one arm accessible for testing
Not Eligible

You will not qualify if you...

  • Diseases that impair neuromuscular function such as myopathies or severe liver and kidney failure
  • Use of drugs that affect neuromuscular function including magnesium and aminoglycosides
  • Pregnancy (pregnancy tests done for women of childbearing age)
  • Breastfeeding
  • Undergoing acute surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 hour during anesthesia

Participants undergo electromyography (EMG) and electroneurography (ENG) testing during anesthesia to assess neuromuscular function using 100 Hz tetanic stimulation.

1 in-person assessment during anesthesia

Trial Site Locations

Total: 2 locations

1

Department of Anesthesiology and Intensive Care, University of Debrecen

Debrecen, Hajdú-Bihar, Hungary, 4032

Not Yet Recruiting

2

University of Debrecen Medical Center, Department of Anesthesiology and Intensive Care

Debrecen, Hungary, 4032

Actively Recruiting

Loading map...

Research Team

A

Adrienn Pongrácz, MD PhD

R

Réka Nemes, MD PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Bl...

Neuromuscular Disease

Actively Recruiting

14 locations

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Stud...

Amyloidosis

Actively Recruiting

101 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here